JP2005278654A - Arthritis-improving food - Google Patents
Arthritis-improving food Download PDFInfo
- Publication number
- JP2005278654A JP2005278654A JP2005151840A JP2005151840A JP2005278654A JP 2005278654 A JP2005278654 A JP 2005278654A JP 2005151840 A JP2005151840 A JP 2005151840A JP 2005151840 A JP2005151840 A JP 2005151840A JP 2005278654 A JP2005278654 A JP 2005278654A
- Authority
- JP
- Japan
- Prior art keywords
- food
- proanthocyanidins
- pine
- arthritis
- opc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 44
- 206010003246 arthritis Diseases 0.000 title abstract description 18
- 150000002337 glycosamines Chemical class 0.000 claims abstract description 23
- 229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 21
- 229920002770 condensed tannin Polymers 0.000 claims description 58
- 235000020741 pine bark extract Nutrition 0.000 claims description 15
- 229940106587 pine bark extract Drugs 0.000 claims description 13
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 12
- MSWZFWKMSRAUBD-IVMDWMLBSA-N glucosamine group Chemical group OC1[C@H](N)[C@@H](O)[C@H](O)[C@H](O1)CO MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 10
- 229960002442 glucosamine Drugs 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 5
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 abstract description 6
- 229920001991 Proanthocyanidin Polymers 0.000 abstract description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 238000000034 method Methods 0.000 description 21
- 208000006820 Arthralgia Diseases 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 15
- 235000005487 catechin Nutrition 0.000 description 15
- 238000000605 extraction Methods 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- 235000010204 pine bark Nutrition 0.000 description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 150000001765 catechin Chemical class 0.000 description 10
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 238000006116 polymerization reaction Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000018646 Pinus brutia Species 0.000 description 8
- 238000009833 condensation Methods 0.000 description 7
- 230000005494 condensation Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 238000000194 supercritical-fluid extraction Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 5
- 235000011613 Pinus brutia Nutrition 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 229950001002 cianidanol Drugs 0.000 description 5
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 229930013915 (+)-catechin Natural products 0.000 description 3
- 235000007219 (+)-catechin Nutrition 0.000 description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 3
- 229920002567 Chondroitin Polymers 0.000 description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- -1 afzelekin Chemical compound 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229940059329 chondroitin sulfate Drugs 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 229930182497 flavan-3-ol Natural products 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- XIMADJWJJOMVID-UHFFFAOYSA-N 2-phenyl-3,4-dihydro-2h-chromene-3,4-diol Chemical compound OC1C(O)C2=CC=CC=C2OC1C1=CC=CC=C1 XIMADJWJJOMVID-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 240000006055 Dacrydium cupressinum Species 0.000 description 2
- 235000018782 Dacrydium cupressinum Nutrition 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 235000005205 Pinus Nutrition 0.000 description 2
- 241000218602 Pinus <genus> Species 0.000 description 2
- 235000013697 Pinus resinosa Nutrition 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229930013884 (+)-gallocatechin Natural products 0.000 description 1
- 235000007243 (+)-gallocatechin Nutrition 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- 229930013783 (-)-epicatechin Natural products 0.000 description 1
- 235000007355 (-)-epicatechin Nutrition 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- OEANUJAFZLQYOD-CXAZCLJRSA-N (2r,3s,4r,5r,6r)-6-[(2r,3r,4r,5r,6r)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](OC)O[C@H](CO)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O1 OEANUJAFZLQYOD-CXAZCLJRSA-N 0.000 description 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- 240000004507 Abelmoschus esculentus Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 235000005638 Austrian pine Nutrition 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 244000067456 Chrysanthemum coronarium Species 0.000 description 1
- 235000007871 Chrysanthemum coronarium Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000218652 Larix Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- 241001133829 Latania Species 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008565 Pinus banksiana Nutrition 0.000 description 1
- 235000000405 Pinus densiflora Nutrition 0.000 description 1
- 240000008670 Pinus densiflora Species 0.000 description 1
- 244000019397 Pinus jeffreyi Species 0.000 description 1
- 235000013264 Pinus jeffreyi Nutrition 0.000 description 1
- 240000007263 Pinus koraiensis Species 0.000 description 1
- 235000011615 Pinus koraiensis Nutrition 0.000 description 1
- 241001236212 Pinus pinaster Species 0.000 description 1
- 235000005105 Pinus pinaster Nutrition 0.000 description 1
- 235000008578 Pinus strobus Nutrition 0.000 description 1
- 235000008585 Pinus thunbergii Nutrition 0.000 description 1
- 235000014030 Podocarpus spicatus Nutrition 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241001495449 Robinia pseudoacacia Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- KBGAYAKRZNYFFG-BOHATCBPSA-N aceneuramic acid Chemical compound OC(=O)C(=O)C[C@H](O)[C@@H](NC(=O)C)[C@@H](O)[C@H](O)[C@H](O)CO KBGAYAKRZNYFFG-BOHATCBPSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical group 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 208000024764 elbow pain Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229960002849 glucosamine sulfate Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- BQINXKOTJQCISL-GRCPKETISA-N keto-neuraminic acid Chemical compound OC(=O)C(=O)C[C@H](O)[C@@H](N)[C@@H](O)[C@H](O)[C@H](O)CO BQINXKOTJQCISL-GRCPKETISA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 235000013842 nitrous oxide Nutrition 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、プロアントシアニジン、およびムコ多糖および/またはアミノ糖を含有する、関節炎改善用食品に関する。 The present invention relates to a food for improving arthritis, which contains proanthocyanidins and mucopolysaccharides and / or amino sugars.
高齢化が進むにつれて、膝や肘の痛みのような関節炎に悩まされる人口が増加しつつあり、このような関節炎を和らげる医薬品や健康食品が市販されている。これには、例えば、コンドロイチン、グルコサミンなどのムコ多糖および/またはアミノ糖を単独で配合した食品、特許文献1に記載のようにグルコサミンとコンドロイチンとを組み合わせた食品などが挙げられる。これらの効果は、広く認められているが、遅効性であり、食品を摂取し始めて1ヶ月程度ではその効果を体感できない。そのため、これらの効果を体感することなく上記食品の摂取を止めてしまう人も多い。
したがって、従来の関節痛などに対して用いられてきた食品の遅効性を改善する、すなわち、短期間で関節痛を和らげる効果を体感できる、食品が求められている。 Therefore, there is a need for foods that can improve the delayed action of foods that have been used for conventional joint pain and the like, that is, can experience the effect of relieving joint pain in a short period of time.
本発明は、(A)プロアントシアニジン、および(B)ムコ多糖および/またはアミノ糖を含有する、関節炎改善用食品を提供する。この食品を摂取することにより、短期間で関節痛を和らげる効果を体感できる。 The present invention provides a food for improving arthritis containing (A) proanthocyanidins and (B) mucopolysaccharides and / or amino sugars. By ingesting this food, you can experience the effect of relieving joint pain in a short period of time.
好ましい実施態様において、上記アミノ糖は、グルコサミンもしくはその誘導体またはそれらの塩である。 In a preferred embodiment, the amino sugar is glucosamine or a derivative thereof or a salt thereof.
別の好ましい実施態様において、上記(A)プロアントシアニジンの20重量%以上は、OPC(oligomeric proanthocyanidin)で構成されている。 In another preferred embodiment, 20% by weight or more of the (A) proanthocyanidin is composed of OPC (oligomeric proanthocyanidin).
本発明はまた、オリゴメリック・プロアントシアニジンを含有する松樹皮抽出物とムコ多糖および/またはアミノ糖とを含有する、食品を提供する。 The present invention also provides a food product comprising a pine bark extract containing oligomeric proanthocyanidins and a mucopolysaccharide and / or amino sugar.
好ましい実施態様において、上記アミノ糖は、グルコサミンもしくはその誘導体またはそれらの塩である。 In a preferred embodiment, the amino sugar is glucosamine or a derivative thereof or a salt thereof.
好ましい実施態様において、上記オリゴメリック・プロアントシアニジンは、松樹皮抽出物に含有されるプロアントシアニジン中に20重量%以上含有されている。 In a preferred embodiment, the oligomeric proanthocyanidins are contained in the proanthocyanidins contained in the pine bark extract in an amount of 20% by weight or more.
本発明によれば、(A)プロアントシアニジン、(B)ムコ多糖および/またはアミノ糖を含有する食品を摂取することにより、関節痛が速効的に軽減されることが見出された。特に、OPCを20重量%以上含有するプロアントシアニジンを使用することにより、効果的に関節痛を軽減できる。 According to the present invention, it has been found that by ingesting a food containing (A) proanthocyanidins, (B) mucopolysaccharides and / or amino sugars, joint pain is rapidly reduced. In particular, joint pain can be effectively reduced by using proanthocyanidins containing 20% by weight or more of OPC.
以下、本発明の関節炎改善用食品について説明する。なお、以下に説明する構成は、本発明を限定するものでなく、本発明の趣旨の範囲内で種々改変することができることは当業者に明らかである。 Hereinafter, the food for improving arthritis of the present invention will be described. The configurations described below are not intended to limit the present invention, and it will be apparent to those skilled in the art that various modifications can be made within the scope of the present invention.
本発明の関節炎改善用食品は、(A)プロアントシアニジン、および(B)ムコ多糖および/またはアミノ糖を含有する。以下、各成分について説明する。 The arthritis improving food of the present invention contains (A) proanthocyanidins, and (B) mucopolysaccharides and / or amino sugars. Hereinafter, each component will be described.
(A)プロアントシアニジン
本発明において、プロアントシアニジンとは、フラバン−3−オールおよび/またはフラバン−3,4−ジオールを構成単位とする重合度が2以上の縮重合体からなる化合物群をいう。プロアントシアニジンは、抗酸化作用などの種々の活性を有することが知られている。
(A) Proanthocyanidin In the present invention, proanthocyanidin refers to a compound group consisting of a condensation polymer having a degree of polymerization of 2 or more having flavan-3-ol and / or flavan-3,4-diol as a structural unit. Proanthocyanidins are known to have various activities such as antioxidant action.
本明細書では、プロアントシアニジンの縮重合体のうち、フラバン−3−オールおよび/またはフラバン−3,4−ジオールを構成単位とする重合度が2〜4の縮重合体を、OPC(オリゴメリック・プロアントシアニジン;oligomeric proanthocyanidin)という。OPCは、ポリフェノールの一種で、植物が作り出す強力な抗酸化物質であり、植物の葉、樹皮、果物の皮もしくは種の部分に集中的に含まれている。具体的には、ブドウの種、松の樹皮、ピーナッツの薄皮、イチョウ、ニセアカシアの果実、コケモモなどに含まれている。また、西アフリカのコーラナッツ、ペルーのラタニアの根、日本の緑茶にも、OPCが含まれることが知られている。OPCは、ヒトの体内では、生成することのできない物質である。 In the present specification, among the condensed polymers of proanthocyanidins, a condensed polymer having a polymerization degree of 2 to 4 having flavan-3-ol and / or flavan-3,4-diol as a structural unit is referred to as OPC (oligomeric).・ Oligomeric proanthocyanidin). OPC is a type of polyphenol, a powerful antioxidant produced by plants, and is concentrated in the leaves, bark, fruit peels or seed parts of plants. Specifically, it is contained in grape seeds, pine bark, peanut thin skin, ginkgo, false acacia fruit, cowberry and the like. It is also known that cola nuts in West Africa, Latania roots in Peru, and Japanese green tea contain OPC. OPC is a substance that cannot be produced in the human body.
本発明の食品に含有されるプロアントシアニジンとして、ブドウ、ブルーベリー、イチゴ、アボガドなどの果実もしくは種子の粉砕物、またはこれらの抽出物のような食品原料を使用することができる。特に、松樹皮の抽出物を用いることが好ましい。松樹皮は、プロアントシアニジンの中でもOPCに富むため、本発明においてプロアントシアニジンの原料として好ましく用いられる。 As the proanthocyanidins contained in the food of the present invention, food raw materials such as pulverized fruits or seeds such as grapes, blueberries, strawberries and avocados, or extracts thereof can be used. In particular, it is preferable to use an extract of pine bark. Since pine bark is rich in OPC among proanthocyanidins, it is preferably used as a raw material for proanthocyanidins in the present invention.
以下、OPCを豊富に含む松樹皮の抽出物を例に挙げて、プロアントシアニジンの調製方法を説明する。 Hereinafter, a method for preparing proanthocyanidins will be described by taking an extract of pine bark rich in OPC as an example.
松樹皮抽出物としては、フランス海岸松(Pinus Martima)、カラマツ、クロマツ、アカマツ、ヒメコマツ、ゴヨウマツ、チョウセンマツ、ハイマツ、リュウキュウマツ、ウツクシマツ、ダイオウマツ、シロマツ、カナダのケベック地方のアネダなどのマツ目に属する植物の樹皮の抽出物が好ましく用いられる。中でも、フランス海岸松(Pinus Martima)の樹皮抽出物が好ましい。 Pine bark extracts include pinus martima, larch, black pine, red pine, Japanese pine, pine pine, Korean pine, red pine, rhubarb pine, pine pine, pine pine, pine of the Quebec region of Canada An extract of the bark of a plant belonging to is preferably used. Among them, a bark extract of French coastal pine (Pinus Martima) is preferable.
フランス海岸松は、南仏の大西洋沿岸の一部に生育している海洋性松をいう。このフランス海岸松の樹皮は、プロアントシアニジン、有機酸、ならびにその他の生理活性成分などを含有し、その主要成分であるフラボノイド類のプロアントシアニジンに、活性酸素を除去する強い抗酸化作用があることが知られている。 French coastal pine is a marine pine that grows on the Atlantic coast of southern France. This French coastal pine bark contains proanthocyanidins, organic acids, and other physiologically active ingredients. The main component of the flavonoids, proanthocyanidins, has a strong antioxidant action to remove active oxygen. Are known.
松樹皮抽出物は、上記の松樹皮を水または有機溶媒で抽出して得られる。水を用いる場合には、温水または熱水が用いられる。抽出に用いる有機溶媒としては、食品あるいは薬剤の製造に許容される有機溶媒が用いられ、例えば、メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール、ブタン、アセトン、ヘキサン、シクロヘキサン、プロピレングリコール、含水エタノール、含水プロピレングリコール、エチルメチルケトン、グリセリン、酢酸メチル、酢酸エチル、ジエチルエーテル、ジクロロメタン、食用油脂、1,1,1,2−テトラフルオロエタン、および1,1,2−トリクロロエテンが挙げられる。これらの水および有機溶媒は単独で用いてもよいし、組合わせて用いてもよい。特に、熱水、含水エタノール、および含水プロピレングリコールが好ましく用いられる。 The pine bark extract is obtained by extracting the pine bark with water or an organic solvent. When water is used, warm water or hot water is used. As an organic solvent used for extraction, an organic solvent that is acceptable for the production of foods or drugs is used. For example, methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, butane, acetone, hexane , Cyclohexane, propylene glycol, hydrous ethanol, hydrous propylene glycol, ethyl methyl ketone, glycerin, methyl acetate, ethyl acetate, diethyl ether, dichloromethane, edible fats and oils, 1,1,1,2-tetrafluoroethane, and 1,1, 2-trichloroethene is mentioned. These water and organic solvent may be used alone or in combination. In particular, hot water, hydrous ethanol, and hydrous propylene glycol are preferably used.
松樹皮からプロアントシアニジンを抽出する方法は、特に限定されないが、例えば、加温抽出法、超臨界流体抽出法などが用いられる。 A method for extracting proanthocyanidins from pine bark is not particularly limited, and for example, a warm extraction method, a supercritical fluid extraction method, or the like is used.
超臨界流体抽出法は、物質の気液の臨界点(臨界温度、臨界圧力)を超えた状態の流体である超臨界流体を用いて目的成分を抽出する方法である。超臨界流体としては、二酸化炭素、エチレン、プロパン、亜酸化窒素(笑気ガス)などが用いられ、二酸化炭素が好ましく用いられる。 The supercritical fluid extraction method is a method in which a target component is extracted using a supercritical fluid that is a fluid that exceeds a critical point (critical temperature, critical pressure) of a gas-liquid substance. As the supercritical fluid, carbon dioxide, ethylene, propane, nitrous oxide (laughing gas) or the like is used, and carbon dioxide is preferably used.
超臨界流体抽出法は、目的成分を超臨界流体によって抽出する抽出工程および目的成分と超臨界流体とを分離する分離工程からなる。分離工程では、圧力変化による抽出分離、温度変化による抽出分離、または吸着剤・吸収剤を用いた抽出分離のいずれを行ってもよい。 The supercritical fluid extraction method includes an extraction step of extracting a target component with a supercritical fluid and a separation step of separating the target component and the supercritical fluid. In the separation step, any one of extraction separation by pressure change, extraction separation by temperature change, or extraction separation using an adsorbent / absorbent may be performed.
また、エントレーナー添加法による超臨界流体抽出を行ってもよい。この方法は、超臨界流体に、例えば、エタノール、プロパノール、n−ヘキサン、アセトン、トルエン、その他の脂肪族低級アルコール類、脂肪族炭化水素類、芳香族炭化水素類、またはケトン類を2〜20W/V%程度添加し、得られた抽出流体で超臨界流体抽出を行うことによって、OPC、カテキン類(後述)などの目的とする被抽出物の抽出流体に対する溶解度を飛躍的に上昇させる、あるいは分離の選択性を増強させる方法であり、効率的に松樹皮抽出物を得る方法である。 Moreover, you may perform supercritical fluid extraction by the entrainer addition method. In this method, 2 to 20 W of ethanol, propanol, n-hexane, acetone, toluene, other aliphatic lower alcohols, aliphatic hydrocarbons, aromatic hydrocarbons, or ketones are added to the supercritical fluid. / V%, and by performing supercritical fluid extraction with the obtained extraction fluid, the solubility of the target extract such as OPC and catechins (described later) in the extraction fluid is dramatically increased, or This is a method for enhancing the selectivity of separation, and a method for efficiently obtaining a pine bark extract.
超臨界流体抽出法は、比較的低い温度で操作できるため、高温で変質・分解する物質にも適用できるという利点;抽出流体が残留しないという利点;および溶媒の循環利用が可能であり、脱溶媒工程などが省略でき、工程がシンプルになるという利点がある。 Since the supercritical fluid extraction method can be operated at a relatively low temperature, it can be applied to substances that are altered or decomposed at high temperatures; the advantage that the extraction fluid does not remain; and the recycling of the solvent is possible. There is an advantage that the process can be omitted and the process becomes simple.
また、松樹皮からの抽出は、上記の方法以外に、液体二酸化炭素回分法、液体二酸化炭素還流法、超臨界二酸化炭素還流法などにより行ってもよい。 Extraction from pine bark may be performed by a liquid carbon dioxide batch method, a liquid carbon dioxide reflux method, a supercritical carbon dioxide reflux method, or the like, in addition to the above method.
松樹皮からの抽出は、複数の抽出方法を組み合わせてもよい。複数の抽出方法を組み合わせることにより、種々の組成の松樹皮抽出物を得ることが可能となる。 For extraction from pine bark, a plurality of extraction methods may be combined. By combining a plurality of extraction methods, it becomes possible to obtain pine bark extracts having various compositions.
本発明の食品に用いられる松樹皮抽出物は、具体的には、以下のような方法によりに調製されるが、これは例示であり、この方法に限定されない。 Specifically, the pine bark extract used in the food of the present invention is prepared by the following method, but this is illustrative and is not limited to this method.
フランス海岸松の樹皮1kgを、塩化ナトリウムの飽和溶液3Lに入れ、100℃にて30分間抽出し、抽出液を得る(抽出工程)。その後、抽出液を濾過し、得られる不溶物を塩化ナトリウムの飽和溶液500mlで洗浄し、洗浄液を得る(洗浄工程)。この抽出液と洗浄液とを合わせて、松樹皮の粗抽出液を得る。 1 kg of French maritime pine bark is placed in 3 L of a saturated solution of sodium chloride and extracted at 100 ° C. for 30 minutes to obtain an extract (extraction process). Thereafter, the extract is filtered, and the resulting insoluble matter is washed with 500 ml of a saturated solution of sodium chloride to obtain a washing solution (washing step). The extract and washing solution are combined to obtain a crude extract of pine bark.
次いで、この粗抽出液に酢酸エチル250mlを添加して分液し、酢酸エチル層を回収する工程を5回行う。回収した酢酸エチル溶液を合わせて、無水硫酸ナトリウム200gに直接添加して脱水する。その後、この酢酸エチル溶液を濾過し、濾液を元の5分の1量になるまで減圧濃縮する。濃縮された酢酸エチル溶液を2Lのクロロホルムに注ぎ、攪拌して得られる沈殿物を濾過により回収する。その後、この沈殿物を酢酸エチル100mlに溶解した後、再度1Lのクロロホルムに添加して沈殿させる操作を2回繰り返す洗浄工程を行う。この方法により、例えば、2〜4量体のOPCを20重量%以上含み、かつカテキン類を5重量%以上含有する、約5gの松樹皮抽出物が得られる。 Next, 250 ml of ethyl acetate is added to the crude extract to separate the solution, and the ethyl acetate layer is recovered five times. The collected ethyl acetate solutions are combined and added directly to 200 g of anhydrous sodium sulfate for dehydration. Thereafter, the ethyl acetate solution is filtered, and the filtrate is concentrated under reduced pressure until the original volume is reduced to 1/5. The concentrated ethyl acetate solution is poured into 2 L of chloroform, and the resulting precipitate is collected by filtration. Thereafter, the precipitate is dissolved in 100 ml of ethyl acetate, and then added to 1 L of chloroform again for precipitation to perform a washing step of repeating twice. By this method, for example, about 5 g of pine bark extract containing 20% by weight or more of 2- to 4-mer OPC and containing 5% by weight or more of catechins can be obtained.
本発明の食品に(A)プロアントシアニジンとして代表的に用いられる、上記の原料植物からの抽出物、特に松樹皮抽出物には、プロアントシアニジン、すなわち、フラバン−3−オールおよび/またはフラバン−3,4−ジオールを構成単位とする重合度が2以上の縮重合体が含まれている。重合度の低い縮重合体が多く含まれるものが好ましく用いられる。重合度の低い縮重合体としては、重合度が2〜30の縮重合体(2〜30量体)が好ましく、重合度が2〜10の縮重合体(2〜10量体)がより好ましく、重合度が2〜4の縮重合体(2〜4量体;すなわち、OPC)がさらに好ましい。 In the extract of the above-mentioned raw material plant, which is typically used as (A) proanthocyanidins in the food of the present invention, particularly pine bark extract, proanthocyanidins, that is, flavan-3-ol and / or flavan-3 Condensation polymers having a degree of polymerization of 2 or more and having 4-diol as a structural unit are contained. Those containing a large amount of a condensation polymer having a low degree of polymerization are preferably used. The condensation polymer having a low polymerization degree is preferably a condensation polymer having a polymerization degree of 2 to 30 (2 to 30 mer), more preferably a condensation polymer having a polymerization degree of 2 to 10 (2 to 10 mer). Further, a condensation polymer having a degree of polymerization of 2 to 4 (2 to 4 mer; that is, OPC) is more preferable.
OPCは、上述のように抗酸化物質であるため、ガン・心臓病・脳血栓などの成人病の危険率を低下する効果、関節炎・アトピー性皮膚炎・花粉症などのアレルギー体質の改善効果なども有する。 As mentioned above, OPC is an antioxidant, so it has the effect of reducing the risk of adult diseases such as cancer, heart disease, and cerebral thrombosis, and allergic constitutions such as arthritis, atopic dermatitis, and hay fever. Have.
さらにOPCは、抗酸化作用のほか、口腔内のバクテリア増殖を抑制してプラーク(歯こう)を減少させる効果;血管の弾力性を回復させる効果;血液中でのリポたんぱくが活性酸素によりダメージを受けるのを防止して、損傷した脂肪が血管の内壁に凝集し、コレステロールが付着することを防止する効果;活性酸素によって分解されたビタミンEを再生させる効果;ビタミンEの増強剤としての効果などを有することが知られている。 In addition to antioxidant activity, OPC suppresses bacterial growth in the oral cavity and reduces plaque (dental glands); restores the elasticity of blood vessels; lipoproteins in the blood are damaged by active oxygen The effect of preventing ingestion and preventing damaged fat from aggregating on the inner wall of blood vessels and adhering cholesterol; the effect of regenerating vitamin E decomposed by active oxygen; the effect of vitamin E as an enhancer, etc. It is known to have
本発明においては、OPCを20重量%以上含有するプロアントシアニジンが好ましく用いられる。より好ましくは30重量%以上である。このようなプロアントシアニジンとして、松樹皮抽出物が好ましく用いられる。 In the present invention, proanthocyanidins containing 20% by weight or more of OPC are preferably used. More preferably, it is 30% by weight or more. As such proanthocyanidins, a pine bark extract is preferably used.
OPC含有量が高いプロアントシアニジンを用いると、重合度の高いプロアントシアニジン(OPC含有量が少ないもの)を用いた場合と対比して、関節痛の緩和に優れた効果が得られる。 When proanthocyanidins having a high OPC content are used, an effect excellent in alleviating joint pain can be obtained as compared with the case of using proanthocyanidins having a high polymerization degree (those having a low OPC content).
また、原料植物由来のプロアントシアニジン、特に植物抽出物には、OPCとともにカテキン(catechin)類が含まれている。カテキン類とは、ポリヒドロキシフラバン−3−オールの総称である。カテキン類としては、(+)−カテキン、(−)−エピカテキン、(+)−ガロカテキン、(−)−エピガロカテキン、エピガロカテキンガレート、エピカテキンガレートなどが知られている。天然物からは、狭義のカテキンといわれている(+)−カテキンの他、ガロカテキン、アフゼレキン、ならびに(+)−カテキンまたはガロカテキンの3−ガロイル誘導体が単離されている。カテキン類には、発癌抑制、動脈硬化予防、脂肪代謝異常の抑制、血圧上昇の抑制、血栓予防、抗アレルギー、抗ウイルス、抗菌、虫歯予防、口臭防止、腸内細菌叢正常化効果、活性酸素やフリーラジカルの消去作用、抗酸化作用などがあることが知られている。また、カテキン類には、血糖の上昇を抑制する抗糖尿病効果があることが知られている。また、カテキン類は、OPCの存在下で水溶性が増すと同時に、活性化する性質がある。 Further, proanthocyanidins derived from raw plants, particularly plant extracts, contain catechins together with OPC. Catechin is a general term for polyhydroxyflavan-3-ol. As catechins, (+)-catechin, (−)-epicatechin, (+)-gallocatechin, (−)-epigallocatechin, epigallocatechin gallate, epicatechin gallate and the like are known. From natural products, in addition to (+)-catechin, which is said to be catechin in the narrow sense, gallocatechin, afzelekin, and (+)-catechin or 3-galloyl derivatives of gallocatechin have been isolated. Catechins include carcinogenesis suppression, prevention of arteriosclerosis, suppression of fat metabolism abnormality, suppression of blood pressure rise, thrombus prevention, antiallergy, antiviral, antibacterial, prevention of bad teeth, prevention of bad breath, normalization of intestinal flora, active oxygen And free radical scavenging action and antioxidant action. In addition, catechins are known to have an antidiabetic effect that suppresses an increase in blood sugar. In addition, catechins have a property of being activated at the same time as water solubility increases in the presence of OPC.
カテキン類は、上記原料植物抽出物に、5重量%以上含有されていることが好ましい。より好ましくは、OPCを20重量%以上含有する原料植物抽出物に、カテキン類が5重量%以上含有されるように調製される。例えば、松樹皮抽出物のカテキン類含量が5重量%未満の場合、カテキン類含量が5重量%以上となるように添加してもよい。カテキン類を5重量%以上含有し、かつOPCを20重量%以上含有する松樹皮抽出物を用いることが最も好ましい。 The catechins are preferably contained in the raw material plant extract in an amount of 5% by weight or more. More preferably, the raw material plant extract containing 20% by weight or more of OPC is prepared so that 5% by weight or more of catechins are contained. For example, when the catechin content of the pine bark extract is less than 5% by weight, it may be added so that the catechin content is 5% by weight or more. It is most preferable to use a pine bark extract containing 5% by weight or more of catechins and 20% by weight or more of OPC.
(B)ムコ多糖および/またはアミノ糖
本発明の関節炎改善用食品は、ムコ多糖および/またはアミノ糖を含む。ムコ多糖には、関節炎の改善、美肌効果、視力改善効果があることが知られている。一方、アミノ糖には、関節炎を改善する作用が知られているが、その他の作用については、ほとんど報告がない。
(B) Mucopolysaccharide and / or amino sugar The food for improving arthritis of the present invention contains mucopolysaccharide and / or amino sugar. Mucopolysaccharides are known to have arthritis improvement, skin beautifying effects, and visual acuity improving effects. On the other hand, amino sugars are known to improve arthritis, but there are few reports on other effects.
本発明の食品に用いられるムコ多糖としては、ヒアルロン酸、コンドロイチン、デルマタン、ヘパラン、ヘパリン、ケタラン、ならびにこれらの塩(例えば、硫酸塩や塩酸塩)が挙げられ、ヒアルロン酸またはコンドロイチンの塩が好ましく用いられる。これらを豊富に含有する食品素材、例えば、鮫や牛の軟骨、鶏皮、ツバメの巣、納豆、オクラなども、ムコ多糖として用いられる。 Examples of the mucopolysaccharide used in the food of the present invention include hyaluronic acid, chondroitin, dermatan, heparan, heparin, ketalan, and salts thereof (for example, sulfate and hydrochloride), and hyaluronic acid or chondroitin salt is preferable. Used. Food materials rich in these, such as salmon and beef cartilage, chicken skin, swallow's nest, natto and okra, are also used as mucopolysaccharides.
アミノ糖としては、グルコサミン、アセチルグルコサミン、ガラクトサミン、アセチルガラクトサミン、ノイラミン酸、アセチルノイラミン酸、ヘキソサミン、およびそれらの塩(例えば、リン酸塩)が挙げられる。これらを豊富に含む食品素材、例えば、鮫や牛の軟骨抽出物も、アミノ糖として好ましく用いられる。 Examples of amino sugars include glucosamine, acetylglucosamine, galactosamine, acetylgalactosamine, neuraminic acid, acetylneuraminic acid, hexosamine, and salts thereof (for example, phosphate). Food materials rich in these, such as salmon and bovine cartilage extracts, are also preferably used as amino sugars.
また、ムコ多糖とアミノ糖とを同時に含有することが好ましい。例えば、いずれをも豊富に含有する鮫や牛の軟骨抽出物が好適である。 Moreover, it is preferable to contain mucopolysaccharide and amino sugar simultaneously. For example, salmon and bovine cartilage extracts that are rich in both are suitable.
本発明の関節炎改善用食品は(A)プロアントシアニジンと(B)ムコ多糖および/またはアミノ糖とを、好ましくは1:1〜50、より好ましくは1:2〜30の重量比で含む。 The arthritis improving food of the present invention contains (A) proanthocyanidins and (B) mucopolysaccharides and / or amino sugars in a weight ratio of preferably 1: 1 to 50, more preferably 1: 2 to 30.
本発明の関節炎改善用食品は、上記(A)プロアントシアニジンおよび(B)ムコ多糖および/またはアミノ糖とを含み、必要に応じて、通常食品に用いられる種々の添加剤も含む。このような添加剤としては、賦形剤、増量剤、結合剤、増粘剤、乳化剤、着色料、香料、食品添加物などが挙げられる。本発明の食品は、例えば、プロアントシアニジンを豊富に含む松樹皮抽出物およびコンドロイチン硫酸に賦形剤などを加えて、錠剤もしくは丸剤などの形状に成形してもよく、あるいは、成形せずに、散剤の形態や、その他の形態としてもよい。これに、さらにグルコサミンを添加するとよい。 The arthritis ameliorating food of the present invention contains (A) proanthocyanidins and (B) mucopolysaccharides and / or amino sugars, and if necessary, various additives commonly used in foods. Examples of such additives include excipients, extenders, binders, thickeners, emulsifiers, colorants, fragrances, food additives, and the like. The food of the present invention may be formed into a shape such as a tablet or a pill by adding an excipient to a pine bark extract rich in proanthocyanidins and chondroitin sulfate, or without molding. A powder form or other forms may be used. It is advisable to add glucosamine to this.
ハードカプセル、ソフトカプセルなどのカプセル剤、粉末状、顆粒状、ティーバッグ状、飴状、液体、ペースト状などの形態としてもよい。 Capsules such as hard capsules and soft capsules, powders, granules, tea bags, baskets, liquids, and pastes may be used.
さらに、例えば、ローヤルゼリー、ビタミン、プロテイン、卵殻カルシウムなどのカルシウム、キトサン、レシチン、クロレラ末、アシタバ末、モロヘイヤ末などの栄養成分を添加することもできる。ステビア末、抹茶パウダー、レモンパウダー、はちみつ、還元麦芽糖、乳糖、糖液、調味料などを加えて味を整えてもよい。 Further, for example, nutritional components such as royal jelly, vitamins, proteins, calcium such as eggshell calcium, chitosan, lecithin, chlorella powder, Ashitaba powder, Moroheiya powder and the like can be added. Stevia powder, matcha powder, lemon powder, honey, reduced maltose, lactose, sugar solution, seasoning, etc. may be added to adjust the taste.
本発明の関節炎改善用食品の摂取方法は、特に限定されない。本発明の食品を、その形状または好みに応じて、そのまま飲食しても良いし、あるいは水、湯、牛乳などに溶いて飲んでも良いし、成分を浸出させたものを飲んでも良い。 The method for ingesting the food for improving arthritis of the present invention is not particularly limited. The food of the present invention may be eaten or consumed as it is depending on its shape or preference, or may be drunk in water, hot water, milk or the like, or may be drunk with a component leached.
本発明の関節炎改善用食品の1日摂取量は、特に限定されないが、(A)プロアントシアニジンとして20〜2000mg、および(B)ムコ多糖としては、50〜2000mg摂取することが好ましい。(B)アミノ多糖としては、50〜2000mg摂取することが好ましい。本発明の食品は、これらの素材を任意の配合比で混合することができる。 The daily intake of the food for improving arthritis of the present invention is not particularly limited, but it is preferable to take 20 to 2000 mg as (A) proanthocyanidins and 50 to 2000 mg as (B) mucopolysaccharides. (B) As an amino polysaccharide, it is preferable to take 50-2000 mg. The foodstuff of this invention can mix these raw materials by arbitrary compounding ratios.
本発明の食品は、(A)プロアントシアニジンが(B)ムコ多糖および/またはアミノ糖の関節痛緩和効果を促進することによって、比較的短期間で関節痛緩和効果が得られると考えられる。 In the food of the present invention, it is considered that (A) proanthocyanidin promotes the joint pain relieving effect of (B) mucopolysaccharide and / or amino sugar, thereby obtaining a joint pain relieving effect in a relatively short period of time.
以下に実施例を挙げて本発明を説明するが、本発明がこの実施例により制限されないことはいうまでもない。 Hereinafter, the present invention will be described with reference to examples, but it goes without saying that the present invention is not limited to these examples.
(実施例1)
プロアントシアニジンを40重量%(OPCを20重量%)およびカテキンを5重量%含有する松樹皮のエタノール抽出物(商品名:フラバンジェノール、株式会社東洋新薬)、グルコサミン、および結晶セルロースを用いて、以下の表1に記載の組成にて混合し、食品1とした。これに、賦形剤、滑沢剤などの成型用剤として、還元麦芽糖、ショ糖エステル、二酸化ケイ素などを適切な割合で混合したものを、食品1と等量混合して、1錠が200mgの重量の錠剤を製造した。
(Example 1)
Using an ethanol extract of pine bark containing 40% by weight of proanthocyanidins (20% by weight of OPC) and 5% by weight of catechin (trade name: Flavangenol, Toyo Shinyaku Co., Ltd.), glucosamine, and crystalline cellulose, The composition shown in Table 1 below was mixed to obtain Food 1. To this, a mixture of reducing maltose, sucrose ester, silicon dioxide, etc. in an appropriate ratio as a molding agent such as an excipient or a lubricant is mixed with food 1 in an equal amount to give 200 mg each tablet. Tablets with a weight of
この錠剤を膝および肘の関節に痛み感じている各5人のボランティア(45歳以上)に1日あたり、12錠を4週間毎日摂取させた。摂取開始後、1週間毎に、関節痛の部位(膝および肘)について、関節痛が、「改善された」・「若干改善された」・「変わらない」の基準で自己評価してもらった。 Each of 5 volunteers (over 45 years old) who felt pain in the knee and elbow joints were given 12 tablets daily for 4 weeks. Every week after the start of ingestion, the joint pains (knees and elbows) were self-assessed based on the criteria of “improved”, “slightly improved”, and “no change” for the sites of joint pain .
結果を表2に示す。なお、表2の数値は、アンケートを行った週までに膝または肘のうちの少なくとも一方の関節痛が、「改善された」か「若干改善された」と答えた人の人数である。 The results are shown in Table 2. The numbers in Table 2 are the number of people who answered that the joint pain in at least one of the knees or elbows was “improved” or “slightly improved” by the week when the questionnaire was conducted.
(実施例2)
グルコサミンの代わりにコンドロイチン硫酸を用い、以下の表1に記載の組成にて食品2を製造した。食品2についても錠剤に成型し、実施例1と同様に関節痛の評価を行った。結果を表2に併せて示す。
(Example 2)
Using chondroitin sulfate instead of glucosamine, food 2 was produced with the composition shown in Table 1 below. Food 2 was also molded into tablets, and joint pain was evaluated in the same manner as in Example 1. The results are also shown in Table 2.
(実施例3)
グルコサミンとコンドロイチン硫酸との両方を用い、以下の表1に記載の組成にて食品3を製造した。食品3についても錠剤に成型し、実施例1と同様に関節痛の評価を行った。結果を表2に併せて示す。
(Example 3)
Using both glucosamine and chondroitin sulfate, food 3 was produced with the composition shown in Table 1 below. Food 3 was also molded into tablets, and joint pain was evaluated in the same manner as in Example 1. The results are also shown in Table 2.
(比較例1〜3)
以下の表1に記載の組成にて(A)および(B)のうちの1種のみを含む食品4〜6を製造し、実施例1と同様に錠剤に成型し、関節痛の評価を行った。結果を表2に併せて示す。
(Comparative Examples 1-3)
The foodstuffs 4-6 which contain only 1 type of (A) and (B) with the composition of the following Table 1 are manufactured, and it shape | molds into a tablet similarly to Example 1, and evaluates joint pain. It was. The results are also shown in Table 2.
表2の結果から、プロアントシアニジンとアミノ糖またはムコ多糖を組み合わせることにより、関節痛の改善が速くなることがわかる(実施例1および2)。また、実施例3の結果から、プロアントシアニジンにムコ多糖とアミノ糖とを同時に配合することにより、さらに速効性に優れることもわかる。 From the results of Table 2, it can be seen that the combination of proanthocyanidins and amino sugars or mucopolysaccharides improves the joint pain faster (Examples 1 and 2). In addition, the results of Example 3 show that the rapid effect is further improved by simultaneously blending mucopolysaccharide and amino sugar with proanthocyanidins.
本発明は、(A)プロアントシアニジン、および(B)ムコ多糖および/またはアミノ糖を含有する、関節炎改善用食品を提供する。この食品を摂取することにより、短期間で関節痛を和らげる効果を体感できる。 The present invention provides a food for improving arthritis containing (A) proanthocyanidins and (B) mucopolysaccharides and / or amino sugars. By ingesting this food, you can experience the effect of relieving joint pain in a short period of time.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005151840A JP2005278654A (en) | 2005-05-25 | 2005-05-25 | Arthritis-improving food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005151840A JP2005278654A (en) | 2005-05-25 | 2005-05-25 | Arthritis-improving food |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002133026A Division JP2003325136A (en) | 2002-05-08 | 2002-05-08 | Arthritis-improving food |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2005278654A true JP2005278654A (en) | 2005-10-13 |
Family
ID=35177700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005151840A Pending JP2005278654A (en) | 2005-05-25 | 2005-05-25 | Arthritis-improving food |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005278654A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016160181A (en) * | 2015-02-26 | 2016-09-05 | 株式会社東洋新薬 | Make-up compositions, cosmetic compositions, compositions for joint protection, compositions |
| JP2016185941A (en) * | 2015-03-27 | 2016-10-27 | 株式会社東洋新薬 | Pine bark extract-containing compositions |
| JP2018100238A (en) * | 2016-12-21 | 2018-06-28 | 花王株式会社 | Ambulatory function improver |
| JP2019062931A (en) * | 2019-02-05 | 2019-04-25 | 株式会社山田養蜂場本社 | Food composition and osteoblast differentiation promoter |
-
2005
- 2005-05-25 JP JP2005151840A patent/JP2005278654A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016160181A (en) * | 2015-02-26 | 2016-09-05 | 株式会社東洋新薬 | Make-up compositions, cosmetic compositions, compositions for joint protection, compositions |
| JP2016185941A (en) * | 2015-03-27 | 2016-10-27 | 株式会社東洋新薬 | Pine bark extract-containing compositions |
| JP2018100238A (en) * | 2016-12-21 | 2018-06-28 | 花王株式会社 | Ambulatory function improver |
| JP2019062931A (en) * | 2019-02-05 | 2019-04-25 | 株式会社山田養蜂場本社 | Food composition and osteoblast differentiation promoter |
| JP7168477B2 (en) | 2019-02-05 | 2022-11-09 | 株式会社山田養蜂場本社 | Food composition and osteoblast differentiation promoter |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003325135A (en) | Health food | |
| KR20210068967A (en) | Composition for relieving and preventing hangover comprising dendropanax morbifera extract | |
| JP2003146898A (en) | Hyperlipemia-improving agent | |
| WO2006011245A1 (en) | Body fat-reducing agent | |
| JP2005097273A (en) | Athletic ability-enhancing composition | |
| JP2006016390A (en) | Proanthocyanidin-containing composition | |
| JP2010159283A (en) | Proanthocyanidin-containing composition | |
| JP2003325136A (en) | Arthritis-improving food | |
| JP2003334022A (en) | Endurance-improving food composition | |
| JP2005097324A (en) | Health food and health beverage | |
| JP2003339353A (en) | Food for beauty | |
| JP2003146899A (en) | Skin-improving agent | |
| JP2004049135A (en) | Health food | |
| JP2005237291A (en) | Health food | |
| JP2003095965A (en) | Hypertension-preventing and treating medicine | |
| JP2005278654A (en) | Arthritis-improving food | |
| JP2005060338A (en) | Proanthocyanidin-including composition | |
| JP2005047839A (en) | Proanthocyanidin-containing composition | |
| JP2003095964A (en) | Anti-stress medicine | |
| JP5681895B2 (en) | Food composition | |
| JP2006022082A (en) | Lipid metabolism improver | |
| JP2005047818A (en) | Health food and health drink | |
| JP4754190B2 (en) | Alcohol metabolism improver | |
| JP2005013208A (en) | Healthy food and healthy drink | |
| JP2005237290A (en) | Health food |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061010 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070306 |